Kia ora,

 

Thank you for your Official Information Act (the Act) request. This is
an automatic reply to let you know we received it.

 

Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. We
will endeavour to acknowledge your request as soon as possible. Further
information about COVID-19 can be found on our
website: [1]https://www.health.govt.nz/our-work/dise...

 

In accordance with the Act, we'll let you know our decision within no more
than 20 working days. If you'd like to calculate the timeframe, you can
use the Ombudsman's online calculator
here: [2]http://www.ombudsman.parliament.nz/

If you have any questions while we're processing your request, please let
us know via [3][email address]

 

Ngā mihi  

OIA Services Team  

   

[4]Ministry of Health information releases  

[5]Unite against COVID-19 

 

 

show quoted sections

References

Visible links
1. https://www.health.govt.nz/our-work/dise...
2. http://scanmail.trustwave.com/?c=15517&a...
3. mailto:[email address]
4. https://www.health.govt.nz/about-ministr...
5. https://covid19.govt.nz/

Kia ora Sue,

 

Thank you for your request for official information, received on 23
November 2021 requesting: 

 

“1) copies all correspondence internal in Medsafe or MinHealth and/ or
between Medsafe, any other employee or agent of Min Health, any Minister
or ministerial advisor, NZ customs, NZ police, Treasury, MBIE/ Pharmac
and/ or NZ Medical Council about the use and/ or any current or proposed
restrictions on use of Ivermectin since 1 December 2019

2) any analysis of the safety and/ or efficacy of Ivermectin for use
treating:

A) any worms, scabies or parasite

B) any respiratory virus and

C) for any other purpose

3) any correspondence about the use of Ivermectin since 1 December 2019
between any employee or agent of MinHealth ( including Medsafe) and any
third party including any pharmaceutical interest, researcher,
international interest or organisation

4) Any Medsafe or MinHealth analysis about any impact or possible impact
of the use of Ivermectin on Covid, or on the uptake of the Pfizervax
Comirnaty and strategies for managing this

5) Any analysis by any person other than a representative of Medsafe or
MinHealth by accessible by MinHealth about any impact or possible impact
of the use of Ivermectin on Covid, or on the uptake of the Pfizervax
Comirnaty, obligations to Pfizer and/ or strategies for managing this.” 

 

We are contacting you in accordance with section 18B of the Official
Information Act 1982 (the Act) as your request, as it is currently worded,
necessitates a search through the inboxes of every staff member and every
team within the Ministry.  Your request may be refused under section 18(f)
of the Act as the information requested cannot be made available without
substantial collation or research.  

 

If it is possible for you to narrow the scope of your request by refining
to a specific team with the Ministry i.e Medsafe only, selecting a shorter
time frame and/ or specifying a topic, we may be able to provide you with
information.  

 

Please respond by 6 December 2021 so that we can consider your refinement
in our response to your request. 

 

We look forward to receiving your response. 

Ngâ mihi  

 

OIA Services 

Government Services 

Office of the Director-General 

Ministry of Health 

E: [1][email address] 

 

show quoted sections

References

Visible links
1. mailto:[email address]

Kia ora Sue 

  

Thank you for your request for official information, received by the
Ministry of Health (the Ministry) on 23 November 2021 for:  

  

“1) copies all correspondence internal in Medsafe or MinHealth and/ or
between Medsafe, any other employee or agent of Min Health, any Minister
or ministerial advisor, NZ customs, NZ police, Treasury, MBIE/ Pharmac
and/ or NZ Medical Council about the use and/ or any current or proposed
restrictions on use of Ivermectin since 1 December 2019 

2) any analysis of the safety and/ or efficacy of Ivermectin for use
treating: 

A) any worms, scabies or parasite 

B) any respiratory virus and 

C) for any other purpose 

3) any correspondence about the use of Ivermectin since 1 December 2019
between any employee or agent of MinHealth ( including Medsafe) and any
third party including any pharmaceutical interest, researcher,
international interest or organisation 

4) Any Medsafe or MinHealth analysis about any impact or possible impact
of the use of Ivermectin on Covid, or on the uptake of the Pfizervax
Comirnaty and strategies for managing this 

5) Any analysis by any person other than a representative of Medsafe or
MinHealth by accessible by MinHealth about any impact or possible impact
of the use of Ivermectin on Covid, or on the uptake of the Pfizervax
Comirnaty, obligations to Pfizer and/ or strategies for managing this.” 
 

  

On 29 November 2021, the Ministry contacted you in accordance with section
18B of the Act. You were advised that your request, as it is currently
worded, necessitates a search through the inboxes of every staff member
and every team within the Ministry and were given the opportunity for you
to refine your request. The Ministry has not received a response ​from
you to date. ​As such your request is refused under section 18(f) of the
Act as the information requested cannot be made available without
substantial collation or research. I have considered whether charging or
extending the time to compile the information would enable us to respond,
however, as each piece of correspondence would have to be individually
reviewed, I do not believe it is in the public interest to do so.  

 

Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [1][email address] or by calling 0800
802 602.      

     

Ngā mihi      

     

 

Jan Torres 

Acting Manager, OIA Services 

Office of the Director-General 

show quoted sections

References

Visible links
1. mailto:[email address]